Neil Goldsmith

Director Strategy BaseLaunch

Neil Goldsmith joined BaseLaunch in May 2018. He supports the Basel Life Sciences Accelerator program of as Director Strategy.

Previously, Neil Goldsmith was CEO and board member of Evolva SA, which he co-founded in 2004, taking it from a startup biotech venture to a leading synthetic biology company listed on the Swiss stock exchange. Before that, he co-founded Topotarget A/S, listed on the Copenhagen exchange, and Personal Chemistry AB, now Biotage AB, listed on NASDAQ Stockholm. Previous to that he was founder or early stage manager of various life science ventures.

Neil holds a 1st class honours degree in Zoology from Balliol College, Oxford University and set up his first company straight out of university in 1984. He is a board member of Unibio and Double Bioventures. 

Cookies uses cookies to ensure you get the best service on our website.
By continuing to browse the site, you are agreeing to the use of cookies.